
Loading, please wait...

Loading, please wait...
The choice between an intramedullary nail and sliding hip screw in proximal femoral fractures has often been driven by surgeon preference and fracture pattern. This prospective randomized multicentre study enrolled 684 patients with intertrochanteric or subtrochanteric fractures and compared the TRIGEN INTERTAN nail with a sliding hip screw. The study assessed pain, mobility, complications and functional recovery over one year. The results did not establish a universal clinical superiority of the nail across all outcomes. Differences in postoperative recovery and implant-related complications were relatively nuanced, reinforcing that fixation should be tailored to the individual fracture rather than based solely on the perceived modernity of the device. For clinicians, the evidence is particularly useful because the sample size was large and the study included a broad elderly fracture population. The practical priorities remain reduction quality, stable fixation, controlled loading and minimising complications. In straightforward stable intertrochanteric fractures, a sliding hip screw remains a defensible option; in more unstable configurations, an intramedullary nail may offer advantages. The implant should follow the biomechanics of the fracture, not the other way around.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.

The choice between an intramedullary nail and sliding hip screw in proximal femoral fractures has often been driven by surgeon preference and fracture pattern. This prospective randomized multicentre study enrolled 684 patients with intertrochanteric or subtrochanteric fractures and compared the TRIGEN INTERTAN nail with a sliding hip screw. The study assessed pain, mobility, complications and functional recovery over one year. The results did not establish a universal clinical superiority of the nail across all outcomes. Differences in postoperative recovery and implant-related complications were relatively nuanced, reinforcing that fixation should be tailored to the individual fracture rather than based solely on the perceived modernity of the device. For clinicians, the evidence is particularly useful because the sample size was large and the study included a broad elderly fracture population. The practical priorities remain reduction quality, stable fixation, controlled loading and minimising complications. In straightforward stable intertrochanteric fractures, a sliding hip screw remains a defensible option; in more unstable configurations, an intramedullary nail may offer advantages. The implant should follow the biomechanics of the fracture, not the other way around.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back